MAOB and Parkinson disease: A 15-day treatment with KDS2010 was also more effective than selegiline for alleviation of PD-like pathology in 6-OHDA model mice, suggesting that reversible MAO-B inhibitions are therapeutically favorable to irreversible inhibition.